{
    "root": "db9c7b16-d22e-472c-928b-8cc426573714",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "TEPYLUTE",
    "value": "20250204",
    "ingredients": [
        {
            "name": "THIOTEPA",
            "code": "905Z5W3GKH"
        },
        {
            "name": "POLYETHYLENE GLYCOL 400",
            "code": "B697894SGQ"
        }
    ],
    "indications": "TEPYLUTE is an alkylating drug indicated for treatment of adenocarcinoma of the breast or ovary. ( 1.1 )",
    "contraindications": "The recommended dose of TEPYLUTE for treatment of adenocarcinoma of the breast or ovary is 0.3 mg/kg to 0.4 mg/kg intravenously. ( 2.1 ) See full prescribing information for preparation instructions. ( 2.2 )",
    "warningsAndPrecautions": "How Supplied\n                        \n                        TEPYLUTE injection is supplied as a clear, colorless or almost colorless solution. The vial stopper is not made with natural rubber latex.\n                        TEPYLUTE Injection\n                        \n                           \n                           \n                              \n                                 \n                                     NDC Number\n                                 \n                                 \n                                     Strength\n                                 \n                                 \n                                     Vial Presentation\n                                 \n                              \n                              \n                                  81927-105-01\n                                  15 mg/ 1.5 mL (10 mg/mL)\n                                  Single-dose vial, carton of 1\n                              \n                              \n                                  81927-106-01\n                                  100 mg/ 10 mL (10 mg/mL)\n                                  Multiple-dose vial, carton of 1",
    "adverseReactions": "TEPYLUTE is contraindicated in:\n                  \n                     Patients with severe hypersensitivity to thiotepa [see Warnings and Precautions (5.2)]\n                     \n                     Concomitant use with live or attenuated vaccines [see Warnings and Precautions (5.4)]"
}